We first confirmed the enhanced tumor progression of human lung cancer induced by TLR9 signaling, and found that CpG ODNs treatment of 95D cells significantly enhanced their proliferation in vitro and tumor progression in vivo (Figure 1A and B, p<0.05). The gene discussed is TLR9; the disease is lung cancer.